CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Option exercise Chief Technology Officer acquired 40,000 shares (option exercise)
- 4 Open-market sale Chief Legal Officer sold 9,160 shares at $4.17 ($38,234)
- 4 Open-market sale Chief Financial Officer sold 19,260 shares at $4.10 ($78,927)
- 4 Open-market sale President and CEO sold 23,637 shares at $4.15 ($98,141)
- 4 Open-market sale Chief Technology Officer sold 5,679 shares at $4.17 ($23,704)
- 4 Open-market sale Chief Commercial Officer sold 4,889 shares at $4.10 ($20,035)
- 4 Grant or award Director acquired 30,952 shares (grant or award)
- 4 Grant or award Director acquired 30,952 shares (grant or award)
- 4 Grant or award Director acquired 30,952 shares (grant or award)
- 4 Grant or award Director acquired 30,952 shares (grant or award)
- 4 Grant or award Director acquired 30,952 shares (grant or award)
- 4 Open-market buy Director bought 90,525 shares at an average $4.22 ($381,958)
- 4 Open-market buy Director bought 98,782 shares at an average $3.81 ($376,429)
- 4 Open-market buy Director bought 128,189 shares at an average $3.52 ($451,734)
- 4 Grant or award EVP, Research & Development acquired 12,767 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 13,066 shares at $3.48 ($45,430)
- 4 Grant or award Chief Commercial Officer acquired 6,631 shares (grant or award)
- 4 Grant or award Director acquired 74,766 shares (grant or award)
Page 4 of 12 · 225 filings